标题/作者	年份
Extrapulmonary manifestations of COVID-19 A Gupta, MV Madhavan, K Sehgal, N Nair, S Mahajan, TS Sehrawat, ... Nature medicine 26 (7), 1017-1032	2020
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study L Carsana, A Sonzogni, A Nasr, RS Rossi, A Pellegrinelli, P Zerbi, R Rech, ... The Lancet infectious diseases 20 (10), 1135-1140	2020
SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14	2020
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447	2020
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment A Parasher Postgraduate medical journal 97 (1147), 312-320	2021
The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections J Machhi, J Herskovitz, AM Senan, D Dutta, B Nath, MD Oleynikov, ... Journal of Neuroimmune Pharmacology 15, 359-386	2020
A comprehensive review of COVID-19 characteristics H Esakandari, M Nabi-Afjadi, J Fakkari-Afjadi, N Farahmandian, ... Biological procedures online 22 (1), 1-10	2020
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection S Pons, S Fodil, E Azoulay, L Zafrani Critical care 24 (1), 1-8	2020
Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19 GN Nadkarni, A Lala, E Bagiella, HL Chang, PR Moreno, E Pujadas, ... Journal of the American College of Cardiology 76 (16), 1815-1826	2020
Early evidence of pronounced brain involvement in fatal COVID-19 outcomes CH von Weyhern, I Kaufmann, F Neff, M Kremer The Lancet 395 (10241), e109	2020
Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system K Farsalinos, R Niaura, J Le Houezec, A Barbouni, A Tsatsakis, ... Toxicology reports 7, 658	2020
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review Y Sakr, M Giovini, M Leone, G Pizzilli, A Kortgen, M Bauer, T Tonetti, ... Annals of intensive care 10, 1-13	2020
Antiphospholipid antibodies in patients with COVID‐19: a relevant observation? KMJ Devreese, EA Linskens, D Benoit, H Peperstraete Journal of Thrombosis and Haemostasis 18 (9), 2191-2201	2020
Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar G Giustino, SP Pinney, A Lala, VY Reddy, HA Johnston-Cox, ... Journal of the American College of Cardiology 76 (17), 2011-2023	2020
Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology/vascular medicine GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628	2020
Covid-19: the rollercoaster of fibrin (ogen), d-dimer, von willebrand factor, p-selectin and their interactions with endothelial cells, platelets and erythrocytes C Grobler, SC Maphumulo, LM Grobbelaar, JC Bredenkamp, ... International journal of molecular sciences 21 (14), 5168	2020
A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19) C Danwang, FT Endomba, JR Nkeck, DLA Wouna, A Robert, JJ Noubiap Biomarker research 8 (1), 1-13	2020
Type 3 hypersensitivity in COVID-19 vasculitis L Roncati, G Ligabue, L Fabbiani, C Malagoli, G Gallo, B Lusenti, ... Clinical Immunology 217, 108487	2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking G Magro Virus research 286, 198070	2020
Spectrum of neurological manifestations in Covid-19: a review RK Garg Neurology India 68 (3), 560	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。